Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript

SA Transcripts159.32K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call April 15, 2026 5:00 PM EDT Company Participants Bradford Amman - CFO, Treasurer & SecretaryR. Huntsman - Co-Founder, Chairman of the Board & CEO Conference Call Participants Scott Henry - Alliance Global Partners, Research DivisionRobert Sassoon - Water Tower Research LLC Presentation Operator Good day, everyone, and welcome to the Vivos Full Year 2025 Earnings Conference Call. [Operator Instructions] This conference call is being recorded and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days. I will now hand the call over to Brad Amman, Chief Financial Officer for introductions and the reading of the safe harbor statement. Please go ahead. Bradford AmmanCFO, Treasurer & Secretary Thank you, operator. Hello, everyone, and welcome to our 2025 conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com. With me on the call today is Kirk Huntsman, Vivos Chairman and Chief Executive Officer. Today, we will review the financial results for the full year 2025 as well as more recent developments and Vivos' plans for 2026 and beyond. Following these formal remarks, we will be happy to take questions. I would also like to remind everyone that today's call will contain forward-looking statements from our management made within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities and Exchange Act of 1934 as amended, concerning future events. Words such as aim, may, could, should, projects, expects, intends, plans, believes, anticipates, hopes, estimates, goal and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve significant known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject